IDD, a wholly owned subsidiary of The Institutes for Pharmaceutical Discovery, LLC, is a drug discovery company focused on the rapid translation of early molecular targets into programs whose goal is novel, patentable compounds. IDD partners with universities for developing novel, early stage drug discovery targets into high value, preclinical proof of concept assets to be licensed to pharmaceutical companies worldwide.